1-5 of 5
Mona Elmacken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

Pamela Seam, Upendra Mahat, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Yuxia Jia, Shu Wang, Zhiheng Xu, Yvette Kasamon, Bindu Kanaparu, Nicholas Richardson, Nicole Gormley
Journal: Blood
Blood (2023) 142 (Supplement 1): 6919.
https://doi.org/10.1182/blood-2023-186544
Published: 2023
Journal Articles

Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis

Upendra Mahat, Pamela Seam, Najat Bouchkouj, Poornima Sharma, Helka Peredo-Pinto, Mona Elmacken, Megha Kaushal, Shu Wang, Zhiheng Xu, Yuxia Jia, Nicholas Richardson, Bindu Kanapuru, Yvette Kasamon, Nicole Gormley
Journal: Blood
Blood (2023) 142 (Supplement 1): 4874.
https://doi.org/10.1182/blood-2023-182279
Published: 2023
Journal Articles

Comparative Phosphoproteomics Study Between Obinutuzumab (GA101) Vs. Rituximab (RTX) Against RTX Sensitive/Resistant Burkitt Lymphoma (BL): Differentially Phosphorylated B Cell Receptor, Fc-Gamma Receptor, Phagocytosis and Natural Killer Cell-Mediated Cytotoxicity Signaling Pathway Proteins

Aradhana Tiwari, Delphine CM Rolland, PharmD, PhD, Mona Elmacken, MD, Janet Ayello, MS, Carmella van de Ven, MA, Venkatesha Basrur, PhD, Kevin Conlon, MS, Damine Fermin, PhD, Matthew J. Barth, MD, Christian Klein, PhD, Kojo Elenitoba-Johnson, Megan S Lim, MD PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2015) 126 (23): 1550.
https://doi.org/10.1182/blood.V126.23.1550.1550
Published: 2015
Journal Articles

A Comparative Global Phosphoproteomics Analysis of Obinutuzumab (GA101) Versus Rituximab (RTX) Against RTX Sensitive and Resistant Burkitt Lymphoma (BL) Demonstrates Differential Phosphorylation of Signaling Pathways Proteins

Aradhana Awasthi, PhD, Delphine C.M. Rolland, PharmD, PhD, Mona Elmacken, MD, Christopher Reggio, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Venkatesha Basrur, PhD, Kevin Conlon, MS, Damian Fermin, PhD, Matthew J. Barth, MD, Kojo S.J. Elenitoba-Johnson, MD, Megan S Lim, MD PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2014) 124 (21): 5481.
https://doi.org/10.1182/blood.V124.21.5481.5481
Published: 2014
Journal Articles

Comparative Study of Obinutuzumab (GA101) Vs. Rituximab Against CD20 + rituximab-Sensitive and -Resistant Burkitt (BL) and Acute Lymphoblastic Leukemia (B-ALL): Potential Targeted Therapy in Patients with High Risk BL and Pre-B-ALL

Aradhana Awasthi, PhD, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Mona Elmacken, MD, Christopher Reggio, Matthew J. Barth, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2014) 124 (21): 2251.
https://doi.org/10.1182/blood.V124.21.2251.2251
Published: 2014